Alliancebernstein L.P. Harpoon Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $41,296 - $116,463	-23,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $16,501 - $22,707	-2,900 Reduced 11.11%	23,200 $175,000
Q2 2021 Jul 30, 2021	BUY	$13.81 - $23.25 $149,148 - $251,100	10,800 Added 70.59%	26,100 $362,000
Q1 2021 May 06, 2021	SELL	$17.65 - $24.16 $47,654 - $65,232	-2,700 Reduced 15.0%	15,300 $320,000
Q3 2020 Nov 12, 2020	BUY	$11.01 - $18.52 $15,414 - $25,928	1,400 Added 8.43%	18,000 $306,000
Q2 2020 Aug 13, 2020	BUY	$11.11 - $24.72 $184,426 - $410,352	16,600 New	16,600 $276,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.